Key result
LBBAP with LVEF >35% linked to ~78% lower death or HF hospitalization versus LVEF ≤35%.
Why the study?
The study aimed to compare the effects of left bundle branch area pacing on cardiac function and clinical outcomes in patients with LBBB and LVEF >35% versus ≤35%.
Does left bundle branch area pacing (LBBAP) yield different clinical outcomes and cardiac function improvements in LBBB patients with LVEF >35% compared to those with LVEF ≤35%?
Cohort (n=36)
No
Does left bundle branch area pacing (LBBAP) yield different clinical outcomes and cardiac function improvements in LBBB patients with LVEF >35% compared to those with LVEF ≤35%?
Effect estimate: HR 0.22 (95% CI 0.06-0.75)
Absolute Event Rate: 17.6% vs 45.5%
p-value: p=0.011
LBBAP effectively shortens QRS duration and improves cardiac function in LBBB patients with LVEF <50%, with significantly better clinical outcomes observed in those with early-stage heart failure (LVEF >35%).
LBBAP was associated with fewer HF events in LBBB and LVEF >35%; leaves open whether RCTs will confirm benefit versus alternatives.
Aims The present study aimed to compare the effects of left bundle branch area pacing (LBBAP) on cardiac function and clinical outcomes in patients with left bundle branch block (LBBB) and left ventricular ejection fraction (LVEF) >35 vs. ≤35%. Methods and Results Thirty-six consecutive patients with LBBB and LVEF <50% were enrolled. All patients were followed up for a mean of 6 months. The successful LBBAP was defined as a paced QRS complex presented as right bundle branch block (RBBB) morphology and QRSd < 130 ms. Echocardiography parameters, pacing parameters and clinical outcomes were collected. The successful LBBAP was achieved in 77.8% of all cases (28/36). In LVEF > 35% group (70 ± 8 years, 9 male), the success rate was 81.0% (17/21). QRSd significantly decreased from 174 ± 23 ms to 108 ± 13 ms ( P < 0.001). The pacing threshold and R-wave amplitude were 0.6 ± 0.2 V @ 0.5 ms and 12 ± 7 mV, respectively. In LVEF ≤ 35% group (69 ± 5 years, 9 male), the success rate was 73.3% (11/15) with QRSd decreasing from 188 ± 25 ms to 107 ± 11 ms ( P < 0.001). The hyperresponders to LBBAP (functional recovery and LVEF ≥ 50%) in LVEF > 35% group was 52.9%, which were almost twice of that in LVEF ≤ 35% group (33.3%). Whether patients had LBBAP or left ventricular septal pacing (LVSP), patients in the LVEF > 35% group showed significantly lower incidence of heart failure hospitalizations or death from any cause (hazard ratio in LVEF > 35% group, 0.22; 95%CI, 0.06 to 0.75, P = 0.011). Conclusions LBBAP can significantly shorten the QRSd and improve cardiac function in LBBB patients with either LVEF > 35 or ≤ 35%. LBBAP should be considered as an effective therapy for preventing the deterioration of cardiac function in early-stage heart failure patients with LBBB and LVEF > 35%.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2022) conducted a cohort in Left bundle branch block (LBBB) and heart failure (n=36). Left bundle branch area pacing (LBBAP) in patients with LVEF > 35% vs. Left bundle branch area pacing (LBBAP) in patients with LVEF ≤ 35% was evaluated on Composite of death from any cause or hospitalization for heart failure (HR 0.22, 95% CI 0.06-0.75, p=0.011). Left bundle branch area pacing in patients with left bundle branch block and LVEF > 35% significantly reduced the risk of heart failure hospitalization or death compared to patients with LVEF ≤ 35% (HR 0.22).